多原子整合分析用于监测用梅波利祖马布或奥马利祖马布治疗的严重喘
Nuria Contreras1,2, Andrea Escolar-Peña1, María I Delgado-Dolset1,2
1Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada - Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
Allergy
|December 18, 2024
概括
治疗严重喘的梅波利祖马布和奥马利祖马布药物表现出明显的免疫代谢作用. 确定了用于监测梅波利祖马布的特定生物标志物,有助于在严重喘管理中个性化医疗方法.
科学领域:
- 免疫代谢过程中的免疫代谢.
- 严重的喘病理生理学
- 生物药物治疗治疗方法
背景情况:
- 生物药物对于严重喘管理至关重要.
- 对于Th2阻断的系统性免疫代谢效应的了解很少.
研究的目的:
- 为了阐明从梅波利祖马布和奥马利祖马布治疗中产生的免疫代谢变化.
- 确定用于监测严重喘治疗疗效的生物标志物.
主要方法:
- 对18个月内接受梅波利祖马布 (n=36) 或奥马利祖马布 (n=20) 的严重喘患者的纵向研究.
- 使用向的奥米克,对35种炎症代谢物和45种蛋白质进行血清分析.
- 多原子数据集成 (DIABLO) 和ROC分析用于生物标志物发现.
主要成果:
- 这两种生物药物都改善了临床喘变量.
- 梅波利祖马布治疗显示了特定的代谢和蛋白质概况.
- 生物标志物 (阿拉基酸,油酸等) 与梅波利祖马布疗效相关.
- 奥马利祖马布治疗没有产生显著的生物标志物或独特的个人资料.
结论:
- 梅波利祖马布和奥马利祖马布在严重喘中的不同免疫代谢影响.
- 确定了监测梅波利祖马布治疗的潜在生物标志物.
- 这些发现支持针对严重喘的个性化医疗策略.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349


